Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034924.xml
Download PDF
Nuklearmedizin 2015; 54(04): N32-N33
DOI: 10.1055/s-0037-1616615
DOI: 10.1055/s-0037-1616615
Case report
Pancreatic VIPoma visualized by 68Ga DOTA-NOC PET-CT
Authors
Further Information
Publication History
received:
06 January 2015
accepted in revised form:
20 April 2015
Publication Date:
12 January 2018 (online)
-
References
- 1 Ro C, Chai W, Yu VE, Yu R. Pancreatic neuroendocrine tumors: biology, diagnosis and treatment. Chin J Cancer 2013; 32: 312-324.
- 2 Balachandran A, Tamm EP, Bhosale PR. et al. Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 2013; 38: 342-357.
- 3 Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol 2012; 26: 737-753.
- 4 Camera L, Severino R, Faggiano A. et al. Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma. World J Radiol 2014; 6: 840-845.
- 5 Imeriale A, Rust E, Gabriel S. et al. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. J Nucl Med 2014; 55: 367-372.
- 6 Hartmann H, Freudenberg R, Oehme L. et al. Dosimetric measurements of 68Ga-high affinity DOTATATE: twins in spirit part III. Nuklearmedizin 2014; 53: 211-216.